Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 374

1.

EUROASPIRE V and uncontrolled risk factors in primary prevention: Atherosclerotic cardiovascular disease in the making.

Santos RD.

Eur J Prev Cardiol. 2020 Apr 1:2047487320915662. doi: 10.1177/2047487320915662. [Epub ahead of print] No abstract available.

PMID:
32237891
2.

Elevated Tumor Lactate and Efflux in High-grade Prostate Cancer demonstrated by Hyperpolarized 13C Magnetic Resonance Spectroscopy of Prostate Tissue Slice Cultures.

Sriram R, Van Criekinge M, DeLos Santos J, Ahamed F, Qin H, Nolley R, Santos RD, Tabatabai ZL, Bok RA, Keshari KR, Vigneron DB, Peehl DM, Kurhanewicz J.

Cancers (Basel). 2020 Feb 26;12(3). pii: E537. doi: 10.3390/cancers12030537.

3.

Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.

Santos RD, Stein EA, Hovingh GK, Blom DJ, Soran H, Watts GF, López JAG, Bray S, Kurtz CE, Hamer AW, Raal FJ.

J Am Coll Cardiol. 2020 Feb 18;75(6):565-574. doi: 10.1016/j.jacc.2019.12.020.

4.

Malformation and death X Alcoholism: perspective of Nursing the Theory of Transitions for alcoholic pregnant women.

Caires TLG, Santos RDS.

Rev Bras Enferm. 2020 Feb 10;73(1):e20180233. doi: 10.1590/0034-7167-2018-0233. eCollection 2020. English, Portuguese.

5.

Research in nursing and modification of the knowledge tree in CNPq: contribution to science.

Barros ALBL, Nóbrega MMLD, Santos RDS, Cézar-Vaz MR, Pagliuca LMF.

Rev Bras Enferm. 2020 Feb 10;73(1):e20170911. doi: 10.1590/0034-7167-2017-0911. eCollection 2020. English, Portuguese.

6.

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity.

Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin BA, Zambon A, Barter P, Fruchart JC, Eckel RH, Matsuzawa Y, Després JP.

Nat Rev Endocrinol. 2020 Mar;16(3):177-189. doi: 10.1038/s41574-019-0310-7. Epub 2020 Feb 4. Review.

7.

Relationship between TSH Levels and the Advanced Lipoprotein Profile in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

José F Peixoto de Miranda É, Goulart AC, Sommer Bittencourt M, Santos RD, Blaha MJ, Jones S, Toth PP, Kulkarni K, Santos IS, Lotufo PA, Bensenor IM.

Endocr Res. 2020 Feb 5:1-11. doi: 10.1080/07435800.2020.1721013. [Epub ahead of print]

PMID:
32019383
8.

Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.

Watts GF, Gidding SS, Mata P, Pang J, Sullivan DR, Yamashita S, Raal FJ, Santos RD, Ray KK.

Nat Rev Cardiol. 2020 Jan 23. doi: 10.1038/s41569-019-0325-8. [Epub ahead of print] Review.

PMID:
31974482
9.

Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality: Can the power of zero be expanded beyond the vessels?

Santos RD.

Atherosclerosis. 2020 Feb;294:44-45. doi: 10.1016/j.atherosclerosis.2019.12.019. Epub 2019 Dec 25. No abstract available.

PMID:
31937417
10.

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.

Representatives of the Global Familial Hypercholesterolemia Community, Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, Almahmeed W, Alonso R, Al-Rasadi K, Badimon L, Bernal LM, Bogsrud MP, Braun LT, Brunham L, Catapano AL, Cillíková K, Corral P, Cuevas R, Defesche JC, Descamps OS, de Ferranti S, Eiselé JL, Elikir G, Folco E, Freiberger T, Fuggetta F, Gaspar IM, Gesztes ÁG, Grošelj U, Hamilton-Craig I, Hanauer-Mader G, Harada-Shiba M, Hastings G, Hovingh GK, Izar MC, Jamison A, Karlsson GN, Kayikçioglu M, Koob S, Koseki M, Lane S, Lima-Martinez MM, López G, Martinez TL, Marais D, Marion L, Mata P, Maurina I, Maxwell D, Mehta R, Mensah GA, Miserez AR, Neely D, Nicholls SJ, Nohara A, Nordestgaard BG, Ose L, Pallidis A, Pang J, Payne J, Peterson AL, Popescu MP, Puri R, Ray KK, Reda A, Sampietro T, Santos RD, Schalkers I, Schreier L, Shapiro MD, Sijbrands E, Soffer D, Stefanutti C, Stoll M, Sy RG, Tamayo ML, Tilney MK, Tokgözoglu L, Tomlinson B, Vallejo-Vaz AJ, Vazquez-Cárdenas A, de Luca PV, Wald DS, Watts GF, Wenger NK, Wolf M, Wood D, Zegerius A, Gaziano TA, Gidding SS.

JAMA Cardiol. 2020 Jan 2. doi: 10.1001/jamacardio.2019.5173. [Epub ahead of print]

PMID:
31895433
11.

Transition to motherhood and mothering for women in wheelchairs: a nursing perspective.

Santos LFMD, Janini JP, Souza VM, Santos RDS.

Rev Bras Enferm. 2019 Dec;72(suppl 3):290-296. doi: 10.1590/0034-7167-2018-0843. English, Portuguese.

12.

Absence of Coronary Artery Calcification in Middle Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease.

Mszar R, Grandhi GR, Valero-Elizondo J, Virani SS, Blankstein R, Blaha M, Mata P, Miname MH, Al Rasadi K, Krumholz HM, Santos RD, Nasir K.

JACC Cardiovasc Imaging. 2019 Nov 11. pii: S1936-878X(19)30962-3. doi: 10.1016/j.jcmg.2019.11.001. [Epub ahead of print] No abstract available.

PMID:
31843585
13.

Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease.

Feng M, Darabi M, Tubeuf E, Canicio A, Lhomme M, Frisdal E, Lanfranchi-Lebreton S, Matheron L, Rached F, Ponnaiah M, Serrano CV Jr, Santos RD, Brites F, Bolbach G, Gautier E, Huby T, Carrie A, Bruckert E, Guerin M, Couvert P, Giral P, Lesnik P, Le Goff W, Guillas I, Kontush A.

Eur J Prev Cardiol. 2019 Dec 15:2047487319894114. doi: 10.1177/2047487319894114. [Epub ahead of print]

14.

Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes.

Ramin-Mangata S, Wargny M, Pichelin M, Le May C, Thédrez A, Blanchard V, Nativel B, Santos RD, Benseñor IM, Lotufo PA, Lambert G, Cariou B.

Atherosclerosis. 2020 Jan;293:49-56. doi: 10.1016/j.atherosclerosis.2019.11.027. Epub 2019 Nov 28.

PMID:
31835041
15.

Very high LDL cholesterol: The power of zero passes another test.

Bittencourt MS, Nasir K, Santos RD, Al-Mallah MH.

Atherosclerosis. 2020 Jan;292:207-208. doi: 10.1016/j.atherosclerosis.2019.11.019. Epub 2019 Nov 17. No abstract available.

PMID:
31806204
16.

The direct and indirect effects of the pneumococcal conjugated vaccine on carriage rates in children aged younger than 5 years in Latin America and the Caribbean: a systematic review.

Silva SM, Rodrigues ICG, Santos RDS, Ternes YMF.

Einstein (Sao Paulo). 2019 Nov 25;18:eRW4890. doi: 10.31744/einstein_journal/2020RW4890. eCollection 2020. English, Portuguese.

17.

Lomitapide and Mipomersen-Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis.

Blom DJ, Raal FJ, Santos RD, Marais AD.

Curr Atheroscler Rep. 2019 Nov 19;21(12):48. doi: 10.1007/s11883-019-0809-3. Review.

PMID:
31741187
18.

Systematics of the genus Maietta Alexander with description of three new species (Diptera: Tipulomorpha: Limoniidae).

Santos D, Santos RDR, Ribeiro GC.

Zootaxa. 2019 Nov 11;4695(4):zootaxa.4695.4.2. doi: 10.11646/zootaxa.4695.4.2.

PMID:
31719340
19.

Vascular age derived from coronary artery calcium score on the risk stratification of individuals with heterozygous familial hypercholesterolaemia.

Miname MH, Bittencourt MS, Pereira AC, Jannes CE, Krieger JE, Nasir K, Santos RD.

Eur Heart J Cardiovasc Imaging. 2020 Mar 1;21(3):251-257. doi: 10.1093/ehjci/jez280.

PMID:
31702778
20.

Association of dietary components with dyslipidemia and low-grade inflammation biomarkers in adults with heterozygous familial hypercholesterolemia from different countries.

Antoniazzi L, Arroyo-Olivares R, Bittencourt MS, Tada MT, Lima I, Jannes CE, Krieger JE, Pereira AC, Quintana-Navarro G, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Mata P, Santos RD.

Eur J Clin Nutr. 2019 Dec;73(12):1622-1625. doi: 10.1038/s41430-019-0529-3. Epub 2019 Nov 6.

PMID:
31695140
21.

Hyperpolarized in vivo pH imaging reveals grade-dependent acidification in prostate cancer.

Korenchan DE, Bok R, Sriram R, Liu K, Santos RD, Qin H, Lobach I, Korn N, Wilson DM, Kurhanewicz J, Flavell RR.

Oncotarget. 2019 Oct 22;10(58):6096-6110. doi: 10.18632/oncotarget.27225. eCollection 2019 Oct 22.

22.

High-density Lipoprotein-cholesterol Subfractions and Coronary Artery Calcium: The ELSA-Brasil Study.

Generoso G, Bensenor IM, Santos RD, Staniak HL, Sharovsky R, Santos IS, Goulart AC, Jones SR, Kulkarni KR, Blaha MJ, Toth PP, Lotufo PA, Bittencourt MS.

Arch Med Res. 2019 Aug;50(6):362-367. doi: 10.1016/j.arcmed.2019.10.006. Epub 2019 Oct 31.

PMID:
31678894
23.

Effects of exogenous amylase on the in vitro digestion kinetics of whole-crop maize silages made from flint or dent grain type at different phenological stages grown in tropical condition.

Silva AS, Pereira LGR, Pedreira MDS, Machado FS, Campos MM, Cortinhas CS, Acedo TS, Dos Santos RD, Rodrigues JPP, Maurício RM, Tomich TR.

J Anim Physiol Anim Nutr (Berl). 2020 Jan;104(1):76-87. doi: 10.1111/jpn.13234. Epub 2019 Oct 31.

PMID:
31674065
24.

Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.

Miname MH, Santos RD.

Prog Cardiovasc Dis. 2019 Sep - Oct;62(5):414-422. doi: 10.1016/j.pcad.2019.10.003. Epub 2019 Oct 25. Review.

PMID:
31669498
25.

Predicting intention to participate in self-management behaviors in patients with Familial Hypercholesterolemia: A cross-national study.

Hagger MS, Hamilton K, Hardcastle SJ, Hu M, Kwok S, Lin J, Nawawi HM, Pang J, Santos RD, Soran H, Su TC, Tomlinson B, Watts GF.

Soc Sci Med. 2019 Dec;242:112591. doi: 10.1016/j.socscimed.2019.112591. Epub 2019 Oct 7.

PMID:
31630009
26.

Early and Late Mortality Following Discharge From the ICU: A Multicenter Prospective Cohort Study.

Rosa RG, Falavigna M, Robinson CC, Sanchez EC, Kochhann R, Schneider D, Sganzerla D, Dietrich C, Barbosa MG, de Souza D, Rech GS, Dos Santos RDR, da Silva AP, Santos MM, Dal Lago P, Sharshar T, Bozza FA, Teixeira C; Quality of Life After ICU Study Group Investigators and the BRICNet.

Crit Care Med. 2020 Jan;48(1):64-72. doi: 10.1097/CCM.0000000000004024.

PMID:
31609775
27.

Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia.

Cao YX, Liu HH, Jin JL, Sun D, Guo YL, Wu NQ, Zhu CG, Xu RX, Sun J, Santos RD, Li JJ.

Eur J Prev Cardiol. 2019 Oct 11:2047487319880985. doi: 10.1177/2047487319880985. [Epub ahead of print]

PMID:
31604401
28.

SPPARM alpha: the Lazarus effect.

Fruchart JC, Santos RD.

Curr Opin Lipidol. 2019 Dec;30(6):419-427. doi: 10.1097/MOL.0000000000000640.

PMID:
31577610
29.

Bringing interleukin-6 complexity to preventive cardiology practice?

Santos RD, Rocha VZ.

Eur J Prev Cardiol. 2020 Jan;27(2):119-121. doi: 10.1177/2047487319876765. Epub 2019 Sep 19. No abstract available.

PMID:
31537123
30.

The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study.

Blom DJ, Santos RD, Daclin V, Mercier F, Ruiz AJ, Danchin N; ICLPS study group.

Eur J Prev Cardiol. 2019 Sep 19:2047487319871735. doi: 10.1177/2047487319871735. [Epub ahead of print]

PMID:
31533447
31.

Update on genetics and molecular biology.

Santos RD, Chacra AP.

Curr Opin Lipidol. 2019 Oct;30(5):414-416. doi: 10.1097/MOL.0000000000000633. No abstract available.

PMID:
31460946
32.

A new dawn for managing dyslipidemias: The era of rna-based therapies.

Macchi C, Sirtori CR, Corsini A, Santos RD, Watts GF, Ruscica M.

Pharmacol Res. 2019 Dec;150:104413. doi: 10.1016/j.phrs.2019.104413. Epub 2019 Aug 23. Review.

PMID:
31449975
33.

Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?

Fruchart JC, Santos RD, Yamashita S, Libby P; International Atherosclerosis Society/R3i Foundation Consensus Panel.

Diabetes Metab Syndr. 2019 Jul - Aug;13(4):2723-2725. doi: 10.1016/j.dsx.2019.05.034. Epub 2019 May 30. Review. No abstract available.

PMID:
31405699
34.

Screening and management of familial hypercholesterolemia.

Santos RD.

Curr Opin Cardiol. 2019 Sep;34(5):526-530. doi: 10.1097/HCO.0000000000000660. Review.

PMID:
31393421
35.

Impact of improved low-density lipoprotein cholesterol assessment on guideline classification in the modern treatment era-Results from a racially diverse Brazilian cross-sectional study.

Pallazola VA, Sathiyakumar V, Ogunmoroti O, Fashanu O, Jones SR, Santos RD, Toth PP, Bittencourt MS, Duncan BB, Lotufo PA, Bensenor IM, Blaha MJ, Martin SS.

J Clin Lipidol. 2019 Sep - Oct;13(5):804-811.e2. doi: 10.1016/j.jacl.2019.07.002. Epub 2019 Jul 9.

PMID:
31383603
36.

Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies.

Raal FJ, Tuomilehto J, Sposito AC, Fonseca FA, Averna M, Farnier M, Santos RD, Ferdinand KC, Wright RS, Navarese EP, Lerch DM, Louie MJ, Lee LV, Letierce A, Robinson JG.

J Clin Lipidol. 2019 Sep - Oct;13(5):735-743. doi: 10.1016/j.jacl.2019.06.006. Epub 2019 Jun 29.

37.

PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival.

Batsios G, Viswanath P, Subramani E, Najac C, Gillespie AM, Santos RD, Molloy AR, Pieper RO, Ronen SM.

Sci Rep. 2019 Jul 19;9(1):10521. doi: 10.1038/s41598-019-47021-x.

38.

Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.

Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart JC, Eckel RH; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity.

Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. doi: 10.1016/S2213-8587(19)30084-1. Epub 2019 Jul 10. Review.

39.

Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study.

Blom DJ, Almahmeed W, Al-Rasadi K, Azuri J, Daclin V, Kayikcioglu M, Mercier F, Ruiz AJ, Santos RD; ICLPS study group.

J Clin Lipidol. 2019 Jul - Aug;13(4):594-600. doi: 10.1016/j.jacl.2019.05.004. Epub 2019 May 14.

40.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

41.

Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia.

Ben-Omran T, Masana L, Kolovou G, Ariceta G, Nóvoa FJ, Lund AM, Bogsrud MP, Araujo M, Hussein O, Ibarretxe D, Sanchez-Hernández RM, Santos RD.

Adv Ther. 2019 Jul;36(7):1786-1811. doi: 10.1007/s12325-019-00985-8. Epub 2019 May 17.

42.

Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia.

Pérez de Isla L, Ray KK, Watts GF, Santos RD, Alonso R, Muñiz-Grijalvo O, Diaz-Diaz JL, Badimon L, Catapano AL, Mata P.

Atherosclerosis. 2019 Jul;286:40-45. doi: 10.1016/j.atherosclerosis.2019.05.003. Epub 2019 May 4.

PMID:
31100618
43.

HDL-cholesterol level and mortality occurrence in the elderly: is the good cholesterol always good?

Santos RD, Barter PJ.

J Clin Endocrinol Metab. 2019 May 16. pii: jc.2019-00845. doi: 10.1210/jc.2019-00845. [Epub ahead of print] No abstract available.

PMID:
31095332
44.

The influence of MTHFR C677T polymorphism in chronic lymphocytic leukemia.

Reis AADS, de Alcântara KC, de Farias DLC, Dos Anjos LRB, Rodrigues DA, Pedrino GR, Santos RDS.

Electrophoresis. 2019 Jul;40(12-13):1715-1718. doi: 10.1002/elps.201800402. Epub 2019 May 2.

PMID:
31020666
45.

Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency.

Zakiev E, Rached F, Lhomme M, Darabi-Amin M, Ponnaiah M, Becker PH, Therond P, Serrano CV Jr, Santos RD, Chapman MJ, Orekhov A, Kontush A.

J Clin Lipidol. 2019 May - Jun;13(3):468-480.e8. doi: 10.1016/j.jacl.2019.02.004. Epub 2019 Feb 25.

PMID:
31003938
46.

Baseline LDL-C levels and risk of cardiovascular events: is there any room for questions?

Rocha VZ, Santos RD.

Int J Cardiol. 2019 Jul 1;286:166-167. doi: 10.1016/j.ijcard.2019.03.058. Epub 2019 Mar 29. No abstract available.

PMID:
30975446
47.

Case report: The efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child.

Chacra APM, Ferrari MC, Rocha VZ, Santos RD.

J Clin Lipidol. 2019 May - Jun;13(3):397-401. doi: 10.1016/j.jacl.2019.03.001. Epub 2019 Mar 11.

PMID:
30948303
48.

Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".

Pang J, Chan DC, Hu M, Muir LA, Kwok S, Charng MJ, Florkowski CM, George PM, Lin J, Loi DD, Marais AD, Nawawi HM, Gonzalez-Santos LE, Su TC, Truong TH, Santos RD, Soran H, Tomlinson B, Yamashita S, Ademi Z, Watts GF.

J Clin Lipidol. 2019 Mar - Apr;13(2):287-300. doi: 10.1016/j.jacl.2019.01.009. Epub 2019 Jan 25.

PMID:
30797720
49.

Inadequate control of atherosclerotic cardiovascular disease risk factors in Europe: EUROASPIRE repeats itself.

Santos RD.

Eur J Prev Cardiol. 2019 May;26(8):820-823. doi: 10.1177/2047487319831476. Epub 2019 Feb 20. No abstract available.

PMID:
30782013
50.

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia.

Ginsberg HN, Tuomilehto J, Hovingh GK, Cariou B, Santos RD, Brown AS, Sanganalmath SK, Koren A, Thompson D, Raal FJ.

Cardiovasc Drugs Ther. 2019 Feb;33(1):69-76. doi: 10.1007/s10557-019-06852-6.

Supplemental Content

Loading ...
Support Center